P09172 (DOPO_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 29, 2013.
Version 151.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Dopamine beta-hydroxylase EC=1.14.17.1 Alternative name(s): Dopamine beta-monooxygenase Cleaved into the following chain: | ||
| Gene names |
| ||
| Organism | Homo sapiens (Human) [Reference proteome] | ||
| Taxonomic identifier | 9606 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 617 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Conversion of dopamine to noradrenaline. |
| Catalytic activity | 3,4-dihydroxyphenethylamine + ascorbate + O2 = noradrenaline + dehydroascorbate + H2O. |
| Cofactor | Binds 1 PQQ per subunit. Binds 2 copper ions per subunit. |
| Pathway | |
| Subunit structure | Homotetramer composed of two non-covalently bound disulfide-linked dimers. |
| Subcellular location | Soluble dopamine beta-hydroxylase: Cytoplasmic vesicle › secretory vesicle lumen. Cytoplasmic vesicle › secretory vesicle › chromaffin granule lumen. Cytoplasmic vesicle › secretory vesicle membrane; Single-pass type II membrane protein. Cytoplasmic vesicle › secretory vesicle › chromaffin granule membrane; Single-pass type II membrane protein Potential. |
| Induction | Activity is enhanced by nerve growth factor (in superior cervical ganglia and adrenal medulla). Trans-synaptic stimulation with reserpine, acetylcholine and glucocorticoids. |
| Polymorphism | There are two main alleles of DBH: DBH-A with Ala-318 and DBH-B with Ser-318. |
| Involvement in disease | Dopamine beta-hydroxylase deficiency (DBH deficiency) [MIM:223360]: Characterized by profound deficits in autonomic and cardiovascular function, but apparently only subtle signs, if any, of central nervous system dysfunction. |
| Sequence similarities | Belongs to the copper type II ascorbate-dependent monooxygenase family. Contains 1 DOMON domain. |
| Sequence caution | The sequence AAH17174.1 differs from that shown. Reason: Erroneous initiation. The sequence CAA31631.1 differs from that shown. Reason: Erroneous initiation. The sequence CAA31632.1 differs from that shown. Reason: Erroneous initiation. The sequence CAA68285.1 differs from that shown. Reason: Erroneous initiation. |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||
Molecule processing | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 617 | 617 | Dopamine beta-hydroxylase | PRO_0000006356 | |||||||
| Chain | 40 – 617 | 578 | Soluble dopamine beta-hydroxylase | PRO_0000308209 | |||||||
Regions | |||||||||||
| Topological domain | 1 – 16 | 16 | Cytoplasmic Potential | ||||||||
| Transmembrane | 17 – 37 | 21 | Helical; Signal-anchor for type II membrane protein; Potential | ||||||||
| Topological domain | 38 – 617 | 580 | Intragranular Potential | ||||||||
| Domain | 57 – 173 | 117 | DOMON | ||||||||
Sites | |||||||||||
| Active site | 230 | 1 | Potential | ||||||||
| Active site | 412 | 1 | Potential | ||||||||
| Metal binding | 262 | 1 | Copper A By similarity | ||||||||
| Metal binding | 263 | 1 | Copper A By similarity | ||||||||
| Metal binding | 333 | 1 | Copper A By similarity | ||||||||
| Metal binding | 412 | 1 | Copper B By similarity | ||||||||
| Metal binding | 414 | 1 | Copper B By similarity | ||||||||
| Metal binding | 487 | 1 | Copper B By similarity | ||||||||
Amino acid modifications | |||||||||||
| Glycosylation | 64 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 184 | 1 | N-linked (GlcNAc...) Ref.6 | ||||||||
| Disulfide bond | 154 ↔ 596 | By similarity | |||||||||
| Disulfide bond | 232 ↔ 283 | By similarity | |||||||||
| Disulfide bond | 269 ↔ 295 | By similarity | |||||||||
| Disulfide bond | 390 ↔ 503 | By similarity | |||||||||
| Disulfide bond | 394 ↔ 565 | By similarity | |||||||||
| Disulfide bond | 466 ↔ 488 | By similarity | |||||||||
| Disulfide bond | 528 | Interchain By similarity | |||||||||
| Disulfide bond | 530 | Interchain By similarity | |||||||||
Natural variations | |||||||||||
| Natural variant | 12 | 1 | G → S. Corresponds to variant rs5318 [ dbSNP | Ensembl ]. | VAR_048838 | |||||||
| Natural variant | 101 | 1 | V → M in DBH deficiency. Ref.11 | VAR_022758 | |||||||
| Natural variant | 114 | 1 | D → E in DBH deficiency. Ref.11 | VAR_022759 | |||||||
| Natural variant | 181 | 1 | E → Q. Corresponds to variant rs5319 [ dbSNP | Ensembl ]. | VAR_014706 | |||||||
| Natural variant | 211 | 1 | A → T. Ref.2 Ref.10 Corresponds to variant rs5320 [ dbSNP | Ensembl ]. | VAR_013947 | |||||||
| Natural variant | 239 | 1 | K → N. Corresponds to variant rs5321 [ dbSNP | Ensembl ]. | VAR_014707 | |||||||
| Natural variant | 250 | 1 | E → Q. Corresponds to variant rs5323 [ dbSNP | Ensembl ]. | VAR_014708 | |||||||
| Natural variant | 290 | 1 | D → N. Corresponds to variant rs5324 [ dbSNP | Ensembl ]. | VAR_014709 | |||||||
| Natural variant | 317 | 1 | L → P. Corresponds to variant rs5325 [ dbSNP | Ensembl ]. | VAR_014710 | |||||||
| Natural variant | 318 | 1 | A → S in allele DBH-B. Ref.7 Ref.8 Ref.10 Corresponds to variant rs4531 [ dbSNP | Ensembl ]. | VAR_002196 | |||||||
| Natural variant | 345 | 1 | D → N in DBH deficiency. Ref.11 | VAR_022760 | |||||||
| Natural variant | 549 | 1 | R → C. Ref.2 Ref.8 Corresponds to variant rs6271 [ dbSNP | Ensembl ]. | VAR_013948 | |||||||
Experimental info | |||||||||||
| Sequence conflict | 505 | 1 | S → T in CAA68285. Ref.2 | ||||||||
| Sequence conflict | 505 | 1 | S → T in CAA31631. Ref.4 | ||||||||
| Sequence conflict | 505 | 1 | S → T in CAA31632. Ref.4 | ||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "DNA sequence and analysis of human chromosome 9." Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S., Bagguley C.L. Dunham I.Nature 429:369-374(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [2] | "The primary structure of human dopamine-beta-hydroxylase: insights into the relationship between the soluble and the membrane-bound forms of the enzyme." Lamouroux A., Vigny A., Faucon Biguet N., Darmon M.C., Franck R., Henry J.-P., Mallet J. EMBO J. 6:3931-3937(1987) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 2-617, PARTIAL PROTEIN SEQUENCE, VARIANTS THR-211 AND CYS-549. |
| [3] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 3-617. Tissue: Brain. |
| [4] | "Human dopamine beta-hydroxylase gene: two mRNA types having different 3'-terminal regions are produced through alternative polyadenylation." Kobayashi K., Kurosawa Y., Fukita K., Nagatsu T. Nucleic Acids Res. 17:1089-1102(1989) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 5-617. |
| [5] | "Expression of human dopamine beta-hydroxylase in Drosophila Schneider 2 cells." Li B., Tsing S., Kosaka A.H., Nguyen B., Osen E.G., Bach C., Chan H., Barnett J. Biochem. J. 313:57-64(1996) [PubMed] [Europe PMC] [Abstract] Cited for: PROTEIN SEQUENCE OF 40-48. |
| [6] | "Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry." Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E., Moore R.J., Smith R.D. J. Proteome Res. 4:2070-2080(2005) [PubMed] [Europe PMC] [Abstract] Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-184, MASS SPECTROMETRY. Tissue: Plasma. |
| [7] | "No evidence for allelic association between schizophrenia and a functional variant of the human dopamine beta-hydroxylase gene (DBH)." Williams H.J., Bray N., Murphy K.C., Cardno A.G., Jones L.A., Owen M.J. Am. J. Med. Genet. 88:557-559(1999) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT SER-318. |
| [8] | "Characterization of single-nucleotide polymorphisms in coding regions of human genes." Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N., Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L., Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q., Lander E.S. Nat. Genet. 22:231-238(1999) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS SER-318 AND CYS-549. |
| [9] | Erratum Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N., Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L., Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q., Lander E.S. Nat. Genet. 23:373-373(1999) |
| [10] | "Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis." Halushka M.K., Fan J.-B., Bentley K., Hsie L., Shen N., Weder A., Cooper R., Lipshutz R., Chakravarti A. Nat. Genet. 22:239-247(1999) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS THR-211 AND SER-318. |
| [11] | "Mutations in the dopamine beta-hydroxylase gene are associated with human norepinephrine deficiency." Kim C.-H., Zabetian C.P., Cubells J.F., Cho S., Biaggioni I., Cohen B.M., Robertson D., Kim K.-S. Am. J. Med. Genet. 108:140-147(2002) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS DBH DEFICIENCY MET-101; GLU-114 AND ASN-345. |
| + | Additional computationally mapped references. |
Web resources
| GeneReviews |
| Wikipedia Dopamine beta hydroxylase entry |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AL365494 Genomic DNA. Translation: CAI13354.2. Y00096 mRNA. Translation: CAA68285.1. Different initiation. BC017174 mRNA. Translation: AAH17174.1. Different initiation. X13255 mRNA. Translation: CAA31631.1. Different initiation. X13256 mRNA. Translation: CAA31632.1. Different initiation. |
| IPI | IPI00171678. |
| PIR | S03020. |
| RefSeq | NP_000778.3. NM_000787.3. |
| UniGene | Hs.591890. |
3D structure databases | |
| ProteinModelPortal | P09172. |
| ModBase | Search... |
Protein-protein interaction databases | |
| MINT | MINT-2843963. |
| STRING | 9606.ENSP00000376776. |
PTM databases | |
| PhosphoSite | P09172. |
Polymorphism databases | |
| DMDM | 158517849. |
Proteomic databases | |
| PaxDb | P09172. |
| PRIDE | P09172. |
Protocols and materials databases | |
| DNASU | 1621. |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000393056; ENSP00000376776; ENSG00000123454. |
| GeneID | 1621. |
| KEGG | hsa:1621. |
| UCSC | uc004cel.3. human. |
Organism-specific databases | |
| CTD | 1621. |
| GeneCards | GC09P136501. |
| H-InvDB | HIX0008510. |
| HGNC | HGNC:2689. DBH. |
| HPA | HPA005960. |
| MIM | 223360. phenotype. 609312. gene. |
| neXtProt | NX_P09172. |
| Orphanet | 230. Dopamine beta-hydroxylase deficiency. |
| PharmGKB | PA136. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | NOG286384. |
| HOGENOM | HOG000063669. |
| HOVERGEN | HBG005519. |
| InParanoid | P09172. |
| KO | K00503. |
| OMA | GAKAFYY. |
| OrthoDB | EOG4SN1ND. |
Enzyme and pathway databases | |
| BioCyc | MetaCyc:MONOMER66-381. |
| Reactome | REACT_111217. Metabolism. |
| SignaLink | P09172. |
| UniPathway | UPA00748; UER00735. |
Gene expression databases | |
| ArrayExpress | P09172. |
| Bgee | P09172. |
| CleanEx | HS_DBH. |
| Genevestigator | P09172. |
| GermOnline | ENSG00000123454. Homo sapiens. |
Family and domain databases | |
| Gene3D | 2.60.120.230. 1 hit. 2.60.120.310. 1 hit. |
| InterPro | IPR014784. Cu2_ascorb_mOase-like_C. IPR020611. Cu2_ascorb_mOase_CS-1. IPR014783. Cu2_ascorb_mOase_CS-2. IPR000323. Cu2_ascorb_mOase_N. IPR005018. DOMON_domain. IPR000945. Dopamine_b_mOase. IPR008977. PHM/PNGase_F_dom. [Graphical view] |
| PANTHER | PTHR10157. PTHR10157. 1 hit. |
| Pfam | PF01082. Cu2_monooxygen. 1 hit. PF03351. DOMON. 1 hit. [Graphical view] |
| PRINTS | PR00767. DBMONOXGNASE. |
| SMART | SM00664. DoH. 1 hit. [Graphical view] |
| SUPFAM | SSF49742. PHM_PNGase_F. 2 hits. |
| PROSITE | PS00084. CU2_MONOOXYGENASE_1. 1 hit. PS00085. CU2_MONOOXYGENASE_2. 1 hit. PS50836. DOMON. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| BindingDB | P09172. |
| ChEMBL | CHEMBL3102. |
| DrugBank | DB00988. Dopamine. DB00126. Vitamin C. |
| GenomeRNAi | 1621. |
| NextBio | 6654. |
| SOURCE | Search... |
Entry information
| Entry name | DOPO_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P09172 Secondary accession number(s): Q5T381, Q96AG2 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 9 Human chromosome 9: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PATHWAY comments Index of metabolic and biosynthesis pathways |
| SIMILARITY comments Index of protein domains and families |

Clusters with
